Aguilar JB, Faust JS, Westafer LM, Gutierrez JB (2020) Investigating the impact of asymptomatic carriers on COVID-19 Transmission. medRxiv
Bixler D (2020) SARS-CoV-2–associated deaths among persons aged 21 Years—United States, February 12–July 31, 2020. MMWR. Morbidity and mortality weekly report, 69
Boon AC, Finkelstein D, Zheng M, Liao G, Allard J, Klumpp K, Webster R, PeltzG Webby RJ (2011) H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load. MBio. https://doi.org/10.1128/mBio.00171-11
Article
PubMed
PubMed Central
Google Scholar
Brierley I, Digard P, Inglis SC (1989) Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell 57(4):537–547
CAS
Article
Google Scholar
Chu H, Chan JF, Yuen TT, Shuai H, Yuan S, Wang Y, Hu B, Yip CC, Tsang JO, Huang X, Chai Y (2020) Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. The Lancet Microbe 1(1):e14–e23
CAS
Article
Google Scholar
De Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TNB, Hoang DM, Chau NVV, Khanh TH, Dong VC, Qui PT (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12(10):1203–1207
Article
Google Scholar
Dubois J, Terrier O, Rosa-Calatrava M (2014) Influenza viruses and mRNA splicing: doing more with less. MBio. https://doi.org/10.1128/mBio.00070-14
Article
PubMed
PubMed Central
Google Scholar
Firth AE, Jagger BW, Wise HM, Nelson CC, Parsawar K, Wills NM, Napthine S, Taubenberger JK, Digard P, Atkins JF (2012) Ribosomal frameshifting used in influenza a virus expression occurs within the sequence UCC_UUU_CGU and is in the+ 1 direction. Open Biol 2(10):120109
CAS
Article
Google Scholar
He G, Sun W, Fang P, Huang J, Gamber M, Cai J, Wu J (2020) The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou. J Med Virol 92(10):1761–1763
CAS
Article
Google Scholar
Hilgenfeld R, Peiris M (2013) From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antivir Res 100(1):286–295
CAS
Article
Google Scholar
Jacks T, Madhani HD, Masiarz FR, Varmus HE (1988) Signals for ribosomal frameshifting in the rous sarcoma virus gag-pol region. Cell 55(3):447–458
CAS
Article
Google Scholar
Johansson MJ, Esberg A, Huang B, Björk GR, Byström AS (2008) Eukaryotic wobble uridine modifications promote a functionally redundant decoding system. Mol Cell Biol 28(10):3301–3312
CAS
Article
Google Scholar
Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845
CAS
Article
Google Scholar
Klein S, Cortese M, Winter SL, Wachsmuth-Melm M, Neufeldt CJ, Cerikan B, Stanifer ML, Boulant S, Bartenschlager R, Chlanda P (2020) SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. Nat Commun 11(1):1–10
Article
Google Scholar
Knoops K, Kikkert M, Van Den Worm SH, Zevenhoven-Dobbe JC, Van Der Meer Y, Koster AJ, Mommaas AM, Snijder EJ (2008) SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 6(9):e226
Article
Google Scholar
Letunic I, Doerks T, Bork P (2015) SMART: recent updates, new developments and status in 2015. Nucleic Acids Res 43(D1):D257–D260
CAS
Article
Google Scholar
Leung K, Pei Y, Leung GM, Lam TT, Wu JT (2020) Empirical transmission advantage of the D614G mutant strain of SARS-CoV-2. medRxiv.
Li R, Ma X, Deng J, Chen Q, Liu W, Peng Z, Qiao Y, LinY He X, Zhang H (2021) Differential efficiencies to neutralize the novel mutants B. 1.1. 7 and 501Y. V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques. Cell Mol Immunol 18(4):1058–1060
CAS
Article
Google Scholar
Muller C, Karl N, Ziebuhr J, Pleschka S (2016) D, L-Lysine acetylsalicylate+ glycine impairs coronavirus replication. J Antivir Antiretrovir 8:142–150
Article
Google Scholar
Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR, Linton NM (2020) Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 94:154
CAS
Article
Google Scholar
Pessa HK, Will CL, Meng X, Schneider C, Watkins NJ, Perälä N, Nymark M, Turunen JJ, Lührmann R, Frilander MJ (2008) Minor spliceosome components are predominantly localized in the nucleus. Proc Natl Acad Sci 105(25):8655–8660
CAS
Article
Google Scholar
Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, Storgaard M, Khalili AS, Simonsen L (2020) Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis 20(9):e238–e244
CAS
Article
Google Scholar
Ratajczak MZ, Kucia M (2020) SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine “storm” and risk factor for damage of hematopoietic stem cells. Leukemia 34(7):1726–1729
CAS
Article
Google Scholar
Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331(5):991–1004
CAS
Article
Google Scholar
Snijder EJ, Van Der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM (2006) Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80(12):5927–5940
CAS
Article
Google Scholar
Song PL, Xie J, Hou Y, You C (2020) Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 509:280–287
CAS
Article
Google Scholar
Starr TN, GreaneyAJ AA, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD (2021) Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371(6531):850–854
CAS
Article
Google Scholar
Stertz S, Reichelt M, Spiegel M, Kuri T, Martínez-Sobrido L, García-Sastre A, Weber F, Kochs G (2007) The intracellular sites of early replication and budding of SARS-coronavirus. Virology 361(2):304–315
CAS
Article
Google Scholar
Yu X, Yang R (2020) COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses 14(4):474–475
CAS
Article
Google Scholar
Wong CH, Ngan CY, Goldfeder RL, Idol J, Kuhlberg C, Maurya R, Kelly K, Omerza G, Renzette N, De Abreu F, Li L (2021) Subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection. bioRxiv
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML (2020) A new coronavirus associated with human respiratory disease in China. Nature 579(7798):265–269
CAS
Article
Google Scholar
Wu Q, Krainer AR (1996) U1-mediated exon definition interactions between AT-AC and GT-AG introns. Science 274(5289):1005–1008
CAS
Article
Google Scholar
Zhou R, Li F, Chen F, Liu H, Zheng J, Lei C, Wu X (2020) Viral dynamics in asymptomatic patients with COVID-19. Int J Infect Dis 96:288–290
CAS
Article
Google Scholar